PubMed

High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myeloma.

Dimopoulos MA, Barlogie B, Smith TL, Alexanian R.

Ann Intern Med. 1991 Dec 15;115(12):931-5.PMID: 1952489 [PubMed - indexed for MEDLINE]Related articles

High serum levels of lactic dehydrogenase identify a high-grade lymphoma-like myeloma.

Barlogie B, Smallwood L, Smith T, Alexanian R.

Ann Intern Med. 1989 Apr 1;110(7):521-5.PMID: 2647015 [PubMed - indexed for MEDLINE]Related articles

High serum lactate dehydrogenase level predicts short survival after vincristine-doxorubicin-dexamethasone (VAD) salvage for refractory multiple myeloma.

Suguro M, Kanda Y, Yamamoto R, Chizuka A, Hamaki T, Matsuyama T, Takezako N, Miwa A, Togawa A.

Am J Hematol. 2000 Oct;65(2):132-5.PMID: 10996830 [PubMed - indexed for MEDLINE]Related articles

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.PMID: 12042984 [PubMed - indexed for MEDLINE]Related articles

Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.

Turen S, Ozyar E, Altundag K, Gullu I, Atahan IL.

Cancer Invest. 2007 Aug;25(5):315-21.PMID: 17661206 [PubMed - indexed for MEDLINE]Related articles

Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study.

Gordon LI, Andersen J, Colgan J, Glick J, Resnick GD, O'Connell M, Cassileth PA.

Cancer. 1995 Feb 1;75(3):865-73.PMID: 7530168 [PubMed - indexed for MEDLINE]Related articles

Impact of early response to sequential high-dose chemotherapy on outcome of patients with advanced myeloma and poor prognostic features.

Niesvizky R, Siegel D, Glassman J, Straus D, Fine J, Lyons L, Michaeli J.

Leuk Lymphoma. 2002 Mar;43(3):607-12.PMID: 12002766 [PubMed - indexed for MEDLINE]Related articles

Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration.

Terpos E, Katodritou E, Tsiftsakis E, Kastritis E, Christoulas D, Pouli A, Michalis E, Verrou E, Anargyrou K, Tsionos K, Dimopoulos MA, Zervas K; Greek Myeloma Study Group.

Haematologica. 2009 Mar;94(3):372-9.PMID: 19252175 [PubMed - indexed for MEDLINE]Related articlesFree article

Lactate dehydrogenase and its isoenzymes in serum from patients with multiple myeloma.

Copur S, Kus S, Kars A, Renda N, Tekuzman G, Firat D.

Clin Chem. 1989 Sep;35(9):1968-70.PMID: 2776328 [PubMed - indexed for MEDLINE]Related articlesFree article

[The significance of lactate dehydrogenase and beta 2-microglobulin levels for the assessment of the prognosis and choice of therapy in multiple myeloma]

Iakovleva SV, Andreeva NE, Izgorodin AS.

Ter Arkh. 1995;67(7):35-9. Russian. PMID: 7482303 [PubMed - indexed for MEDLINE]Related articles

Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine.

Di Raimondo F, Giustolisi R, Lerner S, Cacciola E, O'Brien S, Kantarjian H, Keating MJ.

Ann Oncol. 2001 May;12(5):621-5.PMID: 11432619 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic value of serum lactic dehydrogenase (S-LDH) in multiple myeloma.

Simonsson B, Brenning G, Källander C, Ahre A.

Eur J Clin Invest. 1987 Aug;17(4):336-9.PMID: 3117570 [PubMed - indexed for MEDLINE]Related articles

VAD-PECC regimen in the treatment of advanced-stage multiple myeloma.

Delain M, Linassier C, Petitdidier C, Goupille P, Luthier F, Combe M, Reisenleiter M, Benboubker L, Lamagnère JP, Colombat P.

J Clin Oncol. 1994 Dec;12(12):2706-13.PMID: 7989948 [PubMed - indexed for MEDLINE]Related articles

Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease.

Tas F, Aykan F, Alici S, Kaytan E, Aydiner A, Topuz E.

Am J Clin Oncol. 2001 Dec;24(6):547-50.PMID: 11801751 [PubMed - indexed for MEDLINE]Related articles

Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.

Wilder RB, Rodriguez MA, Ha CS, Pro B, Hess MA, Cabanillas F, Cox JD.

Cancer. 2001 Jun 15;91(12):2440-6.PMID: 11413536 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli.

Bacci G, Ferrari S, Bertoni F, Rimondini S, Longhi A, Bacchini P, Forni C, Manfrini M, Donati D, Picci P.

J Clin Oncol. 2000 Jan;18(1):4-11.PMID: 10623687 [PubMed - indexed for MEDLINE]Related articles

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression.

Mateos MV, Hernández JM, Hernández MT, Gutiérrez NC, Palomera L, Fuertes M, Garcia-Sanchez P, Lahuerta JJ, de la Rubia J, Terol MJ, Sureda A, Bargay J, Ribas P, Alegre A, de Arriba F, Oriol A, Carrera D, García-Laraña J, García-Sanz R, Bladé J, Prósper F, Mateo G, Esseltine DL, van de Velde H, San Miguel JF.

Haematologica. 2008 Apr;93(4):560-5. Epub 2008 Mar 5.PMID: 18322252 [PubMed - indexed for MEDLINE]Related articlesFree article

The diagnostic value of pretreatment serum LDH in patients with limited disease small-cell lung carcinoma.

Stokkel MP, Van Eck-Smit BL, Zwinderman AH, Willems LN, Pauwels EK.

Int J Biol Markers. 1997 Oct-Dec;12(4):162-7.PMID: 9582606 [PubMed - indexed for MEDLINE]Related articles

Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients.

Vaccher E, Tirelli U, Spina M, Talamini R, Errante D, Simonelli C, Carbone A.

J Clin Oncol. 1996 Aug;14(8):2217-23.PMID: 8708710 [PubMed - indexed for MEDLINE]Related articles

Prognostic significance of serum lactate dehydrogenase in osteosarcoma of the extremity: experience at Rizzoli on 1421 patients treated over the last 30 years.

Bacci G, Longhi A, Ferrari S, Briccoli A, Donati D, De Paolis M, Versari M.

Tumori. 2004 Sep-Oct;90(5):478-84.PMID: 15656333 [PubMed - indexed for MEDLINE]Related articles